4//SEC Filing
Rothfuss Cristin 4
Accession 0000950170-25-035006
CIK 0000873303other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 8:00 PM ET
Size
6.3 KB
Accession
0000950170-25-035006
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-04$101.34/sh−288$29,186→ 13,037 total - Tax Payment
Common Stock
2025-03-04$101.34/sh−296$29,997→ 13,325 total
Footnotes (1)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002046214
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 8:00 PM ET
- Size
- 6.3 KB